Sinclair Pharma Share News (SPH)

Pharmaceuticals group Sinclair Pharma was lower after it said it will raise up to £25m in a share placing to pay for two major dermatology products as it named Christopher Spooner chief executive officer. Spooner, previously co-founder and chief executive of HealthCor Management UK, will replace Michael Flynn when he retires. Sinclair said it plans to buy the sales and worldwide commercial rights for Flammazine and Flammacerium from Solvay Pharmaceuticals for a total consideration of €17.5m. The two drugs are expected to generate global annual revenues of over £9m.Educational specialist RM Group has had its contract to provide Scotland's national education intranet extended by two years. The contract extension is worth £10m.FTSE TechMARK - FallersInnovation Group (TIG) 12.75p -3.77%Alphameric (ALM) 33.50p -2.90%Ark Therapeutics (AKT) 43.50p -2.79%Sinclair Pharma (SPH) 44.00p -2.22%Kofax (KFX) 160.00p -2.14%NXT (NTX) 14.75p -1.67%Xaar (XAR) 92.00p -1.60%Puricore (PURI) 15.50p -1.59%Biocompatibles International (BII) 206.00p -1.20%Emblaze (BLZ) 42.00p -1.18%FTSE TechMARK - RisersPhytopharm (PYM) 5.75p +12.09%GB Group (GBG) 25.00p +11.11%Intec Telecom (ITL) 110.25p +8.62%KCOM Group (KCOM) 42.00p +5.00%Morse (MOR) 35.00p +4.48%Skyepharma (SKP) 80.00p +3.90%AEA Technology (AAT) 29.50p +2.61%Ricardo Group (RCDO) 260.00p +1.96%Psion (PON) 117.00p +1.74%Optos (OPTS) 90.00p +1.69%